MA50991B1 - Composition topique ophtalmique comprenent de l'acide dobesilique pour le traitement des maladies du segment postérieur de l' il - Google Patents
Composition topique ophtalmique comprenent de l'acide dobesilique pour le traitement des maladies du segment postérieur de l' ilInfo
- Publication number
- MA50991B1 MA50991B1 MA50991A MA50991A MA50991B1 MA 50991 B1 MA50991 B1 MA 50991B1 MA 50991 A MA50991 A MA 50991A MA 50991 A MA50991 A MA 50991A MA 50991 B1 MA50991 B1 MA 50991B1
- Authority
- MA
- Morocco
- Prior art keywords
- eye
- treatment
- acid
- posterior segment
- diseases
- Prior art date
Links
- IKQCSJBQLWJEPU-UHFFFAOYSA-N 2,5-dihydroxybenzenesulfonic acid Chemical compound OC1=CC=C(O)C(S(O)(=O)=O)=C1 IKQCSJBQLWJEPU-UHFFFAOYSA-N 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 229940049636 dobesilic acid Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 3
- 150000002148 esters Chemical class 0.000 abstract 2
- 230000006806 disease prevention Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000001328 optic nerve Anatomy 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000002207 retinal effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382832 | 2017-12-04 | ||
| PCT/EP2018/082999 WO2019110416A1 (en) | 2017-12-04 | 2018-11-29 | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA50991A MA50991A (fr) | 2020-10-14 |
| MA50991B1 true MA50991B1 (fr) | 2023-03-31 |
Family
ID=60673756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA50991A MA50991B1 (fr) | 2017-12-04 | 2018-11-29 | Composition topique ophtalmique comprenent de l'acide dobesilique pour le traitement des maladies du segment postérieur de l' il |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20200390729A1 (https=) |
| EP (1) | EP3720428B1 (https=) |
| JP (1) | JP7846501B2 (https=) |
| KR (1) | KR102756155B1 (https=) |
| CN (1) | CN111542316A (https=) |
| AU (1) | AU2018378981B2 (https=) |
| BR (1) | BR112020011160A2 (https=) |
| CA (1) | CA3083835A1 (https=) |
| CL (1) | CL2020001426A1 (https=) |
| DK (1) | DK3720428T3 (https=) |
| ES (1) | ES2941036T3 (https=) |
| FI (1) | FI3720428T3 (https=) |
| HR (1) | HRP20230319T1 (https=) |
| HU (1) | HUE061852T2 (https=) |
| MA (1) | MA50991B1 (https=) |
| MX (1) | MX2020005809A (https=) |
| MY (1) | MY205498A (https=) |
| PH (1) | PH12020550722A1 (https=) |
| PL (1) | PL3720428T3 (https=) |
| PT (1) | PT3720428T (https=) |
| SG (1) | SG11202004940VA (https=) |
| SI (1) | SI3720428T1 (https=) |
| WO (1) | WO2019110416A1 (https=) |
| ZA (1) | ZA202003944B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202300017430A1 (it) * | 2023-08-22 | 2025-02-22 | Service Biotech srl | Soluzione oftalmica in forma di collirio contenente una isoforma umana ricombinante di manganese superossido dismutasi (rmnsod) per la cura di patologie dell’occhio |
| CN117257963B (zh) * | 2023-11-02 | 2024-07-16 | 广州准优生物科技有限公司 | 含脐带间充质干细胞外泌体的眼用药剂及其制备方法和用途 |
| CN117643573B (zh) * | 2024-01-29 | 2024-05-03 | 天津医科大学眼科医院 | 一种可递送药物至眼后节的纳米滴眼液及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE51421B1 (en) * | 1980-08-01 | 1986-12-24 | Smith & Nephew Ass | Ophthalmic compositions containing triamterene |
| US9198886B2 (en) * | 2006-08-16 | 2015-12-01 | Pedro Cuevas Sánchez | Use of 2,5-dihydroxybenzene for the treatment of ocular diseases |
| JP2015500213A (ja) | 2011-11-30 | 2015-01-05 | ザイジェン インフラメーション リミテッド | 眼乾燥症候群を処置するためのｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤の使用 |
| EP2777699B1 (en) | 2012-02-02 | 2017-03-29 | Invesfovea S.L. | Diethylamine-2,5-dihydroxybenzenesulfonate for the treatment of age-related macular degeneration |
| CA2866405A1 (en) | 2012-03-05 | 2013-09-12 | Wayne State University | Identification of channelopsin-2 (chop2) mutations and methods of use |
| RU2014140116A (ru) | 2012-04-24 | 2016-06-10 | Тромбодженикс Н.В. | Антитела против pdgf-c |
| EP2875811A1 (en) | 2013-11-26 | 2015-05-27 | Luis Antonio Outeirino Miguez | Use of dobesilate for treating ocular haemorrhages |
-
2018
- 2018-11-29 DK DK18811023.3T patent/DK3720428T3/da active
- 2018-11-29 EP EP18811023.3A patent/EP3720428B1/en active Active
- 2018-11-29 MA MA50991A patent/MA50991B1/fr unknown
- 2018-11-29 HR HRP20230319TT patent/HRP20230319T1/hr unknown
- 2018-11-29 MY MYPI2020002628A patent/MY205498A/en unknown
- 2018-11-29 ES ES18811023T patent/ES2941036T3/es active Active
- 2018-11-29 FI FIEP18811023.3T patent/FI3720428T3/fi active
- 2018-11-29 PT PT188110233T patent/PT3720428T/pt unknown
- 2018-11-29 PL PL18811023.3T patent/PL3720428T3/pl unknown
- 2018-11-29 SG SG11202004940VA patent/SG11202004940VA/en unknown
- 2018-11-29 CN CN201880082202.1A patent/CN111542316A/zh active Pending
- 2018-11-29 KR KR1020207018983A patent/KR102756155B1/ko active Active
- 2018-11-29 US US16/770,027 patent/US20200390729A1/en active Pending
- 2018-11-29 HU HUE18811023A patent/HUE061852T2/hu unknown
- 2018-11-29 JP JP2020529733A patent/JP7846501B2/ja active Active
- 2018-11-29 WO PCT/EP2018/082999 patent/WO2019110416A1/en not_active Ceased
- 2018-11-29 AU AU2018378981A patent/AU2018378981B2/en active Active
- 2018-11-29 CA CA3083835A patent/CA3083835A1/en active Pending
- 2018-11-29 BR BR112020011160-0A patent/BR112020011160A2/pt unknown
- 2018-11-29 SI SI201830869T patent/SI3720428T1/sl unknown
- 2018-11-29 MX MX2020005809A patent/MX2020005809A/es unknown
-
2020
- 2020-05-27 PH PH12020550722A patent/PH12020550722A1/en unknown
- 2020-05-28 CL CL2020001426A patent/CL2020001426A1/es unknown
- 2020-06-29 ZA ZA2020/03944A patent/ZA202003944B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI3720428T1 (sl) | 2023-05-31 |
| CA3083835A1 (en) | 2019-06-13 |
| ES2941036T3 (es) | 2023-05-16 |
| EP3720428A1 (en) | 2020-10-14 |
| WO2019110416A1 (en) | 2019-06-13 |
| KR102756155B1 (ko) | 2025-01-20 |
| KR20200096569A (ko) | 2020-08-12 |
| ZA202003944B (en) | 2022-12-21 |
| PH12020550722A1 (en) | 2021-02-15 |
| CN111542316A (zh) | 2020-08-14 |
| JP7846501B2 (ja) | 2026-04-15 |
| HRP20230319T1 (hr) | 2023-05-12 |
| CL2020001426A1 (es) | 2020-11-06 |
| AU2018378981A1 (en) | 2020-07-16 |
| EP3720428B1 (en) | 2023-01-11 |
| BR112020011160A2 (pt) | 2020-11-17 |
| MX2020005809A (es) | 2020-08-20 |
| HUE061852T2 (hu) | 2023-08-28 |
| DK3720428T3 (da) | 2023-03-20 |
| US20200390729A1 (en) | 2020-12-17 |
| JP2021505554A (ja) | 2021-02-18 |
| FI3720428T3 (fi) | 2023-03-30 |
| MA50991A (fr) | 2020-10-14 |
| PT3720428T (pt) | 2023-04-03 |
| PL3720428T3 (pl) | 2023-05-08 |
| MY205498A (en) | 2024-10-23 |
| SG11202004940VA (en) | 2020-06-29 |
| AU2018378981B2 (en) | 2024-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4491229A3 (en) | Coding rna administered into the suprachoroidal space in the treatment of ophtalmic diseases | |
| JP2019524826A5 (https=) | ||
| Samudre et al. | Lacritin, a novel human tear glycoprotein, promotes sustained basal tearing and is well tolerated | |
| EA201000441A1 (ru) | Водные офтальмологические препараты | |
| BR112016025997A8 (pt) | compostos para tratamento de doenças e lesões oftalmológicas, uma composição farmacêutica e uma formulação oftálmica | |
| WO2017158366A3 (en) | Ophthalmic delivery device and ophthalmic drug compositions | |
| WO2007104541A3 (en) | Compositions and methods using serine protease inhibiting peptides for treating ophthalmic disorders | |
| Janowski et al. | Concise review: using stem cells to prevent the progression of myopia—a concept | |
| Lazreg et al. | Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications | |
| EP3934646A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES OR CONDITIONS | |
| MA50991B1 (fr) | Composition topique ophtalmique comprenent de l'acide dobesilique pour le traitement des maladies du segment postérieur de l' il | |
| WO2020212760A3 (en) | Compounds and methods for the treatment of ocular disorders | |
| EP3416617B1 (en) | Combination of an antiallergic agent with muscarinic antagonist and/or dopaminergic agonist for use in preventing/stopping of axial myopia in human | |
| EP3919052A4 (en) | Pharmaceutical composition for intraocular or oral administration for treatment of retinal diseases | |
| WO2013184650A3 (en) | Treatment of ocular inflammatory diseases using laquinimod | |
| Padhy et al. | Bimatoprost (0.03%)-induced accommodative spasm and pseudomyopia | |
| JP2015160826A (ja) | ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤 | |
| MX2025007776A (es) | Conjugados de farmaco para el tratamiento de trastornos oculares | |
| RU2017111579A (ru) | Способы лечения и предотвращения заболеваний глаз, расстройств и патологических состояний меланином и аналогами, предшественниками и производными меланина | |
| EP4559529A3 (en) | Isocyclosporin a for topical treatment of ocular diseases | |
| Jagadeesh et al. | Visual performance with changes in eccentricity in PROSE device: A case report | |
| MX2022006523A (es) | Composicion que comprende budesonida para uso oftalmico. | |
| JP6231783B2 (ja) | 完全フロイントアジュバント投与による眼瞼状態の変化方法 | |
| IT202200008621A1 (it) | Composizione farmaceutica in microemulsione per il trattamento dei disturbi del segmento anteriore dell'occhio | |
| Khandelwal | Ocular snow storm: an unusual presentation of phacolytic glaucoma |